Unique Opportunity to acquire a leading edge testing laboratory, that is ISO and DEA certified. The majority of the testing performed is for exotic cannabinoids, which are hemp/CBD derivatives; a rapidly growing market segment. Seller was a first mover in recognizing the synergies of hemp testing in a DEA certified lab, that also performs CA state licensed cannabis testing. This has given Seller a valuable early lead, in expertise and market share, for full panel cannabinoid testing . Operating since 2008, this laboratory was built and is managed by its founder and seasoned long term employees. Seller uses a sophisticated and robust software system that has been customized to ensure comprehensive and efficient management of laboratory operations, data collection, SOPs and quality control. Lease for 4,000 sq. ft at $6,250 per month NNN expires 6/30/27, up to $7,311.62.65 NNN in final year. The lab is fully outfitted with top-line instrumentation that covers all required and prospective testing requirements. Agilent HPLC's, Shimadzu GC MS/MS, and Perkin-Elmer ICP MS/MS are among the instruments, all purchased new. The lab's technicians have been trained in maintenance and repair of the equipment, ensuring little interruption of operations. 400 Amps of power. Ample parking. In addition to its first mover advantage, Seller has budgeted generously for sales and marketing functions. The internal sales force benefits from the reputation of Seller in the industry and is able to consistently grow sales. Internet based techniques are also successfully employed, including direct email marketing and SEO. Seller’s DEA certification, which takes more than a year to acquire, allows seller to provide any Federal and State hemp and cannabis testing while facing sparse competition. According to industry reports, the US CBD market was approximately $1.6 billion in 2021 and projected to expand at a compound annual growth rate (CAGR) exceeding 40% through 2030. The US hemp oil market, where testing requirements for THC are federally mandated, was 470 million in 2021 and is expected to expand at a CAGR of 18.5%. Seller is well positioned as new markets for hemp testing open up around the globe. Seller is also prepared for testing of psychedelics, once legislation for testing methods/standards is passed in California. Seller is amenable to seller financing for a portion of the purchase price. NDA and POF required.